We further studied the EV-derived mRNA expression of TIMP-1, TIMP-2 and MMP-1 mRNAs in plasma EVs from two groups of ccRCC patients: patients with localized disease before and after tumor removal surgery (Group A) and patients with metastatic disease (Group B). This evidence concerns the gene TIMP2 and metastatic neoplasm.